LTRO, Companies like AAPL and TSLA don't seem too concerned about China despite the fact that Elon Musk owns SpaceX and does not seem worried that China could steal Musk's technology. Should Pfizer acquire AMRN that would reduce the risk that the Chinese would somehow cheat. Then AMRN having access to Mochida's one a day version of Vascepa may be a real game changer in the US especially, and use it to destroy the generics. Eventually, it could be used in foreign countries if exclusivity on Vascepa is lost. Imagine a Pfizer produced one a day version of Vascepa with a statin. Pfizer could also use that in China in time.